Leiomyosarcoma (LMS) Completed Phase 2 Trials for Nivolumab (DB09035)

Back to Leiomyosarcoma (LMS)

Also known as: LMS - Leiomyosarcoma / Leiomyosarcomas / Leiomyosarcoma / Leiomyosarcoma (morphologic abnormality) / Leiomyosarcoma NOS / Leiomyosarcoma (disorder)

IndicationStatusPhase
DBCOND0118909 (Leiomyosarcoma (LMS))Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03241745
A Study of Nivolumab in Selected Uterine Cancer PatientsTreatment